Chronic Future: Killing Cancer Premiered on April 5; Cannabis Science's CEO Dr. Robert Melamede & Filmmaker Henry Miller Weig...
April 12 2012 - 1:45PM
Business Wire
Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech
company developing pharmaceutical cannabis products, is thrilled to
provide an update on the premiere of Chronic Future: Killing
Cancer, a film by Henry Miller and Cory Pritchard. It tells the
story of the attempt by Arizona's governor to close down medical
marijuana dispensaries, and introduces patient after patient, with
debilitating ailments, where medical marijuana has successfully
treated the disease. Cannabis Science's CEO, Dr. Robert Melamede,
was interviewed for the film about the success the company has seen
with patients self-administering cannabis oil to their squamous
cell carcinomas, and reducing their tumor burden, even apparently
eradicating tumors as determined by biopsy.
The film premiered April 5, 2012 in Scottsdale, Arizona,
followed by 3 showings per day. The first five showings were sold
out, with the following ones close to sold out. Henry Miller
states, "There were over 3,500 people who showed up for tickets
throughout the day. We got 3 standing ovations for the very first
showing. Every state that has legal medical marijuana is part of
our formula to fight for federal justice and their acknowledgement
of scientific reality. We touched every state. I'm getting calls
from people all over the world asking how they can get the film. I
haven't had one negative response. [Dr. Melamede] is a genuine,
sincere person; a beautiful soul. We couldn't ask for a better
doctor to be representing this." Miller has received calls from
Japan, China, India, Russia, Great Britain, Germany, Australia,
South Africa, France, and Canada.
In addition to the 3,500 viewers who showed up for tickets, the
movie has caught the attention of celebrities such as Angelina
Jolie. Miller has "tweeted with Angelina Jolie, who saw the clips,
and says she hopes it will end world hunger." Henry Miller hopes to
be interviewed by Howard Stern, 60 Minutes, Good Morning America,
Anderson Cooper, John Stewart, Oprah, David Letterman, and Jimmy
Kimmel, just to name a few. Miller says, "The celebrities are
coming out and seeing what we're doing, and are willing to help us
and support us."
Dr. Robert Melamede commented, "As evidenced by the demographics
of the population attending the opening, it's quite apparent that
medical marijuana has moved out of the counterculture and into the
mainstream of well to do American citizens. People have already
contacted me about the availability of our treatment for skin
cancer."
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical
grade medical marijuana research and development. The second
formulations will address the needs of patients choosing to use
concentrated cannabis extracts to treat their ailments. Eventually,
all Americans will have access to a safe and effective FDA approved
medicine regardless of which state they live in. To maintain that
marijuana is a dangerous, addictive drug with no medical value is
scientifically absurd. Cannabis medicines, with no effective lethal
dose, are far safer than aspirin, acetaminophen, and most other OTC
drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid
science targeting critical illnesses, and adheres to scientific
methodologies to develop, produce and commercialize
phytocannabinoid-based pharmaceutical products. In sum, we are
dedicated to the creation of cannabis-based medicines, both with
and without psychoactive properties, to treat disease and the
symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. Cannabis Science, Inc. does not undertake any duty nor does
it intend to update the results of these forward-looking
statements.